Summary
- Current Price
- As of today, DNLI price is $21.00, down -0.85% on
- Current Price All-Time High
- DNLI price is currently -77.65% below its historical high of $93.94 set on
- Market Cap
- DNLI current market cap is $3B, up +36.37% over the past 365 days
- PE Ratio
- DNLI PE ratio is unknown
- Revenue
- DNLI current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DNLI is on
Profile
| Metric | Value |
|---|---|
| Full Name | Denali Therapeutics Inc. |
| Ticker | NASDAQ: DNLI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | denalitherapeutics.com |
| Employees | 443 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.00 | |
| Price, 1D Change | -0.85% | |
| $3B | ||
| - | ||
| - | ||
| 1.40 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| $0.00 | ||
| EPS, 1Y Change | +100.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| EPS Estimate | N/A | -$2.46 |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | $54.77M |
| Revenue Est. Change | N/A | - |
| Current Price | $21.00 | |
| Price Target | - | $32.00 |
| Price Tgt. Change | - | +52.38% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.75 | -$2.57 | +6.50% | |
| -$3.01 | $0.00 | +100.00% | |
| -$2.46 | N/A | - | |
| -$2.46 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.41M | $0.00 | -100.00% | |
| $2.86M | $0.00 | -100.00% | |
| $54.77M | N/A | - | |
| $149.56M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.00 | |
| $16.19 | ||
| SMA 200 vs Price | -22.89% | |
| $19.11 | ||
| SMA 50 vs Price | -9.01% | |
| 1.40 | ||
| $1.21 | ||
| 54.94 | ||
| 45.29% | ||
| 61.56% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| -$555.34M | ||
| - | ||
| -$512.54M | ||
| - | ||
| -$544.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 9.16 | ||
| 9.16 | ||
| - | ||
| - | ||
| 13.34 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.23 | ||
| -4.51 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.01B | ||
| $867.88M | ||
| $1.14B | ||
| $900.66M | ||
| $131.09M | ||
| $98.35M | ||
| $42.29M | ||
| $9.55M | ||
| $3.33M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $512.54M | ||
| $544.16M | ||
| $11.18M | ||
| $136.56M | ||
| $11.18M | ||
| $0.00 | ||
| $102.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$412.60M | ||
| $255.28M | ||
| $189.22M | ||
| $9.50M | ||
| -$422.10M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wolfe Research | ||
| BTIG | → | |
| Wedbush | → | |
| Wedbush | → | |
| BTIG | → | |
| JP Morgan | → | |
| Cantor Fitzgerald | → | |
| Morgan Stanley | → | |
| B of A Securities | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with DNLI
FAQ
What is the ticker symbol for Denali Therapeutics Inc.?
The ticker symbol for Denali Therapeutics Inc. is NASDAQ:DNLI
Does Denali Therapeutics Inc. pay dividends?
No, Denali Therapeutics Inc. does not pay dividends
What sector is Denali Therapeutics Inc. in?
Denali Therapeutics Inc. is in the Healthcare sector
What industry is Denali Therapeutics Inc. in?
Denali Therapeutics Inc. is in the Biotechnology industry
What country is Denali Therapeutics Inc. based in?
Denali Therapeutics Inc. is headquartered in United States
When did Denali Therapeutics Inc. go public?
Denali Therapeutics Inc. initial public offering (IPO) was on December 8, 2017
Is Denali Therapeutics Inc. in the S&P 500?
No, Denali Therapeutics Inc. is not included in the S&P 500 index
Is Denali Therapeutics Inc. in the NASDAQ 100?
No, Denali Therapeutics Inc. is not included in the NASDAQ 100 index
Is Denali Therapeutics Inc. in the Dow Jones?
No, Denali Therapeutics Inc. is not included in the Dow Jones index
When was Denali Therapeutics Inc. last earnings report?
Denali Therapeutics Inc.'s most recent earnings report was on February 26, 2026
When does Denali Therapeutics Inc. report earnings?
The next expected earnings date for Denali Therapeutics Inc. is May 11, 2026
Data Sources & References
- DNLI Official Website www.denalitherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1714899/000171489926000021/0001714899-26-000021-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489926000021/0001714899-26-000021-index.htm
- DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
- DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli